REGULATORY

• PAFSC’s Second Committee to Discuss Approval for IFN-Free Hepatitis C Treatments on June 26
  June 19, 2014

• Drug Price Settlement Rate for March 2014 at 98.4%: MHLW
  June 19, 2014

• LDP Members Request Govt to Stay with Current Biennial NHI Price Revision
  June 18, 2014

• MHLW on Tap to Launch Expedited Drug Review System in 2015
  June 18, 2014

• Govt Weighs Applying Mixed Care Scheme to Low Cost-Effective Drugs: Draft Growth Strategy
  June 17, 2014

• PMDA Reviewing Osteoporosis Treatment Forteo for Risk of Shock, Anaphylaxis
  June 17, 2014

• “Annual” NHI Price Revision Erased from Gov’t Draft Policy Blueprint
  June 16, 2014

• Regulatory Reform Proposal Including Expansion of Mixed Care Use Submitted to Prime Minister
  June 16, 2014

• LDP Members with Vested Interests Slam Annual NHI Price Revision
  June 12, 2014

• MHLW Panel OKs Draft Report on Medical Database Project, but Further Discussion Needed for Drug Makers’ Usage
  June 12, 2014

• Expansion of “Mixed Care” Cited in Outline for New Growth Strategy
  June 12, 2014

• MHLW to Seek Opinions on Abe’s New Mixed Care Plan from Advisory Panels
  June 11, 2014

• PM Abe Vows to Forge New System to Accelerate Mixed Care
  June 11, 2014

• Health Minister Still Cautious about Annual Drug Price Revision
  June 11, 2014

• Ex-Novartis Employee Nabbed over Diovan Data Tampering: Reports
  June 11, 2014

• Govt Tilting Toward Etching Annual NHI Price Revision in Fiscal Blueprint
  June 10, 2014

• No Complaints Received So Far for Penalty Fee Cuts: MHLW Official
  June 10, 2014

• Japan Sees 53-Month Designation Lag, 54-Month Approval Lag for Orphan Drugs
  June 9, 2014

• MHLW Designates 20 Products including Allegra FX as Drugs Requiring Face-to-Face Consultations
  June 9, 2014

• Researchers Aiming to Craft Guide for Ultra-Orphan Drug Development
  June 9, 2014

ページ

• « 先頭
• ‹ Prev
• …
• 325
• 326
• 327
• 328
• 329
• 330
• 331
• 332
• 333
• …
• Next ›
• 最終 »